AI Summary
We reviewed 125 live results for actemra subcutaneous (sc) injection and narrowed them down to the 3 options that look most worth comparing first.
The strongest themes across this short list are Biologics and Subcutaneous Injections.
Comparison Table
Recommended
Actemra Subcutaneous (SC) Injection
Source: Roche
Description
A ready-to-use subcutaneous injection of tocilizumab available as a 162 mg / 0.9 mL solution in a single-use pre-filled syringe (PFS). This formulation allows for self-administration by patients with rheumatoid arthritis or juvenile idiopathic arthritis, providing a more flexible alternative to clinical infusion sessions. It is registered with the Thai FDA and offers a convenient delivery method for long-term chronic disease management.
Best for
Self-administration at home, Chronic RA maintenance, Patient convenience and Thailand registered biologics
View Details
Rating
Actemra Intravenous (IV) Infusion
Source: Roche
Description
Actemra is an Interleukin-6 (IL-6) receptor antagonist containing the active ingredient tocilizumab. This intravenous formulation is used for treating moderate to severe active Rheumatoid Arthritis (RA), Polyarticular Juvenile Idiopathic Arthritis (pJIA), and Systemic Juvenile Idiopathic Arthritis (sJIA). In Thailand, it is available in 80 mg, 200 mg, and 400 mg vials (20 mg/mL), distributed through DKSH. It is a critical biologic therapy for controlling systemic inflammation and joint damage.
Best for
Rheumatoid arthritis management, Juvenile idiopathic arthritis, Hospital-based IV treatment and Thai local access
View Details
Rating
Hizentra 200mg/ml solution for subcutaneous injection
Source: DKSH Malaysia Sdn Bhd
Description
This 200mg/ml Hizentra solution is the Malaysian-registered formulation (MAL18016154ARZ) provided for replacement therapy in primary immunodeficiency and immunomodulatory therapy in CIDP. It is distributed via authorized healthcare channels by DKSH Malaysia.
Best for
Malaysian healthcare providers, local patient access, authorized pharmaceutical distribution and PI and CIDP therapy in Malaysia
View Details
Rating
| Compare | Actemra Subcutaneous (SC) Injection | Actemra Intravenous (IV) Infusion | Hizentra 200mg/ml solution for subcutaneous injection |
|---|---|---|---|
| Source | Roche | Roche | DKSH Malaysia Sdn Bhd |
| Description | A ready-to-use subcutaneous injection of tocilizumab available as a 162 mg / 0.9 mL solution in a single-use pre-filled syringe (PFS). This formulation allows for self-administration by patients with rheumatoid arthritis or juvenile idiopathic arthritis, providing a more flexible alternative to clinical infusion sessions. It is registered with the Thai FDA and offers a convenient delivery method for long-term chronic disease management. | Actemra is an Interleukin-6 (IL-6) receptor antagonist containing the active ingredient tocilizumab. This intravenous formulation is used for treating moderate to severe active Rheumatoid Arthritis (RA), Polyarticular Juvenile Idiopathic Arthritis (pJIA), and Systemic Juvenile Idiopathic Arthritis (sJIA). In Thailand, it is available in 80 mg, 200 mg, and 400 mg vials (20 mg/mL), distributed through DKSH. It is a critical biologic therapy for controlling systemic inflammation and joint damage. | This 200mg/ml Hizentra solution is the Malaysian-registered formulation (MAL18016154ARZ) provided for replacement therapy in primary immunodeficiency and immunomodulatory therapy in CIDP. It is distributed via authorized healthcare channels by DKSH Malaysia. |
| Best for | Self-administration at home, Chronic RA maintenance, Patient convenience and Thailand registered biologics | Rheumatoid arthritis management, Juvenile idiopathic arthritis, Hospital-based IV treatment and Thai local access | Malaysian healthcare providers, local patient access, authorized pharmaceutical distribution and PI and CIDP therapy in Malaysia |
| Tags | |||
| Action | View Details | View Details | View Details |
| Rating |
AI Recommendation
If you want the most balanced option to start with, I recommend:
"Actemra Subcutaneous (SC) Injection from Roche."
I picked this because Offers the convenience of self-injection for patients in Thailand needing long-term maintenance therapy without frequent hospital visits.
Share this search
Related Finds